CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737

Kazuyuki Shimada, Akihiro Tomita, Yosuke Minami, Akihiro Abe, Charlotte K. Hind, Hitoshi Kiyoi, Mark S. Cragg, Tomoki Naoe

Research output: Contribution to journalArticle

15 Citations (Scopus)

Fingerprint Dive into the research topics of 'CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737'. Together they form a unique fingerprint.

Medicine & Life Sciences